The health care and pharmaceuticals sectors are entering a new phase, mainly characterized by more frequent breakthroughs in the scientific understanding of disease and a new generation of technologies that are significantly impacting the speed and the cost of new drugs. At the same time, the growth of consumerism in the acquisition of health care services is leading to changes in health care products and services worldwide.

Amontis Turnaround Associates assist health care companies with strategy development, plan execution and ongoing monitoring of actual vs. projected results. Listed below are representative assignments undertaken by Amontis Turnaround Associates during the past several years:

  • Reorganized U.S. and European clinical research activities for a global pharmaceutical company, aimed at reducing drug development times by 30%
  • Formulated a multi-year, multi-million drug delivery strategy for a specialized pharmaceutical manufacturing company
  • Planned procurement and distribution strategies for contraceptive products destined for low-income families throughout Latin America
  • Developed a specialized facilities investment program for one of the largest providers of medical services in the U.S.
  • Studied the Middle East potential for health foods and related wellness products